Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) (AXPH) reported a 24.2% year-on-year (YoY) decline in net profits for the first 11 months of fiscal year (FY) 2021/2022, according to the income statement filed to the Egyptian Exchange (EGX) on July 7^th.

Net profits amounted to EGP 12.45 million in the period from July 1^st 2021 to May 31^st 2022, compared to EGP 16.43 million in the same period of FY 2020/2021.

Alex Pharma, a subsidiary of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary, and nutritional food products, as well as medical appliances.